Related Experiment Video
Updated: Aug 9, 2025

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
NPM 1 Mutations in AML-The Landscape in 2023
Naman Sharma1, Jane L Liesveld2
1Department of Hematology and Oncology, University of Massachusetts-Baystate Medical Center, Springfield, MA 01199, USA.
NPM1 mutations are key in Acute Myeloid Leukemia (AML), driving disease development and impacting treatment. Novel therapies targeting NPM1 mutations show promising efficacy in clinical trials.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Acute Myeloid Leukemia (AML) is a heterogeneous clonal hematopoietic stem cell disorder.
- NPM1 mutations are prevalent in ~30% of AML cases, often acting as an early oncogenic event.
- NPM1 mutations are associated with specific clinical features and influence diagnosis, prognosis, and treatment.
Purpose of the Study:
- To review the pathophysiology of NPM1 gene mutations in AML.
- To discuss the clinical implications of NPM1 mutations.
- To summarize novel targeted therapies for NPM1-mutated AML.
Main Methods:
- Literature review of pathophysiology, clinical data, and therapeutic strategies.
- Analysis of current clinical trial data for NPM1-targeted therapies.
Main Results:
- NPM1 mutations are critical in AML leukemogenesis and are linked to distinct clinical presentations.
- NPM1 mutations play a significant role in AML diagnosis, prognosis, and monitoring.
- Emerging therapies targeting NPM1 mutations demonstrate significant clinical efficacy.
Conclusions:
- NPM1 mutations are a crucial factor in AML pathogenesis and patient management.
- Targeted therapies for NPM1-mutated AML represent a promising advancement in leukemia treatment.
Related Concept Videos
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Abnormal Proliferation
Differentiation of Common Myeloid Progenitor Cells
Mutations in Microorganisms
Spontaneous and Induced Mutations
Cancers Originate from Somatic Mutations in a Single Cell

